Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation.

Ecsedi, Matyas; Schmohl, Jörg; Zeiser, Robert; Drexler, Beatrice; Halter, Jörg; Medinger, Michael; Duyster, Justus; Kanz, Lothar; Passweg, Jakob; Finke, Jürgen; Bethge, Wolfgang; Lengerke, Claudia

Ecsedi, Matyas; Schmohl, Jörg; Zeiser, Robert; Drexler, Beatrice; Halter, Jörg; Medinger, Michael; Duyster, Justus; Kanz, Lothar; Passweg, Jakob; Finke, Jürgen; Bethge, Wolfgang; Lengerke, Claudia.

Afiliação

Ecsedi M; Division of Hematology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Schmohl J; Department of Hematology and Oncology, Medical Center, University of Tuebingen, 72076, Tuebingen, Germany.
Zeiser R; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, 79106, Freiburg, Germany.
Drexler B; Division of Hematology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Halter J; Division of Hematology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Medinger M; Division of Hematology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Duyster J; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, 79106, Freiburg, Germany.
Kanz L; Department of Hematology and Oncology, Medical Center, University of Tuebingen, 72076, Tuebingen, Germany.
Passweg J; Division of Hematology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Finke J; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, 79106, Freiburg, Germany.
Bethge W; Department of Hematology and Oncology, Medical Center, University of Tuebingen, 72076, Tuebingen, Germany.
Lengerke C; Division of Hematology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. claudia.lengerke@usb.ch.

Ann Hematol ; 95(10): 1627-36, 2016 Oct.

Article em En | MEDLINE | ID: mdl-27480090

Assuntos

Soro Antilinfocitário/efeitos adversos; Transplante de Células-Tronco Hematopoéticas; Hiperbilirrubinemia/etiologia; Imunossupressores/efeitos adversos; Mielofibrose Primária/terapia; Adulto; Idoso; Soro Antilinfocitário/uso terapêutico; Estudos de Casos e Controles; Feminino; Rejeição de Enxerto/prevenção & controle; Doença Enxerto-Hospedeiro/prevenção & controle; Humanos; Hiperbilirrubinemia/imunologia; Imunossupressores/uso terapêutico; Sobrecarga de Ferro/sangue; Sobrecarga de Ferro/etiologia; Fígado/efeitos dos fármacos; Fígado/fisiopatologia; Masculino; Pessoa de Meia-Idade; Mielofibrose Primária/sangue; Linfócitos T/imunologia; Reação Transfusional; Condicionamento Pré-Transplante/métodos; Transplante Homólogo; Adulto Jovem

Palavras-chave

Anti-thymocyte globulin; Bilirubin; Hematopoietic cell transplantation; Hepatic toxicity; Myelofibrosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mielofibrose Primária / Hiperbilirrubinemia / Imunossupressores / Soro Antilinfocitário Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google